TABLE 2

Summary of adverse events due to any cause occurring in >1 subjecta

Adverse eventNo. of subjects with adverse event in treatment group
TQ + DHA-PQP (n = 24)TQ + AL (n = 24)DHA-PQP (n = 24)AL (n = 24)TQ (n = 24)
Fatigue11010
Influenza-like illness11100
Medical device site reaction10200
Asthenia01100
Feeling hot10100
Pyrexia11000
Headache34311
Dizziness02100
Nausea21200
Diarrhea11200
Abdominal pain11000
Contact dermatitis20110
Ventricular tachycardia00110
Upper RTI00011
Throat irritation00110
Decreased appetite01110
  • a TQ, tafenoquine; DHA-PQP, dihydroartemisinin-piperaquine; AL, artemether-lumefantrine; RTI, respiratory tract infection.